Valley National Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $130K | Sell |
5,371
-1,001
| -16% | -$24.2K | 0.02% | 280 |
|
2025
Q1 | $132K | Buy |
+6,372
| New | +$132K | 0.02% | 261 |
|
2024
Q2 | – | Sell |
-1,089
| Closed | -$31K | – | 1174 |
|
2024
Q1 | $31K | Sell |
1,089
-715
| -40% | -$20.4K | ﹤0.01% | 467 |
|
2023
Q4 | $59K | Sell |
1,804
-1,377
| -43% | -$45K | 0.01% | 379 |
|
2023
Q3 | $89K | Sell |
3,181
-1,123
| -26% | -$31.4K | 0.02% | 311 |
|
2023
Q2 | $147K | Hold |
4,304
| – | – | 0.02% | 270 |
|
2023
Q1 | $130K | Sell |
4,304
-15
| -0.3% | -$453 | 0.02% | 272 |
|
2022
Q4 | $135K | Sell |
4,319
-4,045
| -48% | -$126K | 0.02% | 273 |
|
2022
Q3 | $271K | Sell |
8,364
-15,011
| -64% | -$486K | 0.06% | 213 |
|
2022
Q2 | $880K | Buy |
23,375
+3,113
| +15% | +$117K | 0.19% | 100 |
|
2022
Q1 | $931K | Sell |
20,262
-14,744
| -42% | -$677K | 0.18% | 119 |
|
2021
Q4 | $2.14M | Sell |
35,006
-64
| -0.2% | -$3.92K | 0.4% | 70 |
|
2021
Q3 | $2.62M | Buy |
35,070
+2,482
| +8% | +$185K | 0.47% | 44 |
|
2021
Q2 | $3.01M | Buy |
32,588
+3,202
| +11% | +$296K | 0.55% | 30 |
|
2021
Q1 | $2.61M | Buy |
29,386
+2,013
| +7% | +$179K | 0.51% | 35 |
|
2020
Q4 | $2.55M | Buy |
27,373
+5,333
| +24% | +$497K | 0.54% | 33 |
|
2020
Q3 | $1.4M | Buy |
22,040
+1,886
| +9% | +$120K | 0.32% | 52 |
|
2020
Q2 | $1.05M | Sell |
20,154
-1,027
| -5% | -$53.6K | 0.24% | 70 |
|
2020
Q1 | $663K | Sell |
21,181
-2,821
| -12% | -$88.3K | 0.18% | 92 |
|
2019
Q4 | $805K | Buy |
24,002
+10,088
| +73% | +$338K | 0.2% | 90 |
|
2019
Q3 | $411K | Buy |
13,914
+2,362
| +20% | +$69.8K | 0.11% | 130 |
|
2019
Q2 | $398K | Buy |
11,552
+1,574
| +16% | +$54.2K | 0.11% | 127 |
|
2019
Q1 | $328K | Buy |
9,978
+9,369
| +1,538% | +$308K | 0.09% | 142 |
|
2018
Q4 | $15K | Buy |
+609
| New | +$15K | ﹤0.01% | 400 |
|